Is Laparoscopic Roux-en-Y Gastric Bypass Still the Gold Standard Procedure for Indians? Mid- to Long-Term Outcomes from a Tertiary Care Center

التفاصيل البيبلوغرافية
العنوان: Is Laparoscopic Roux-en-Y Gastric Bypass Still the Gold Standard Procedure for Indians? Mid- to Long-Term Outcomes from a Tertiary Care Center
المؤلفون: S Christinajoice, Shyin Palani Prabhakaran, Shivanshu Misra, P Praveen Raj, B Deepa Nandhini, Subodh Kumar, C. Palanivelu
المصدر: Obesity Surgery. 30:4482-4493
بيانات النشر: Springer Science and Business Media LLC, 2020.
سنة النشر: 2020
مصطلحات موضوعية: Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Gastric Bypass, India, 030209 endocrinology & metabolism, Body Mass Index, Tertiary Care Centers, 03 medical and health sciences, 0302 clinical medicine, Gastrectomy, Weight loss, medicine, Humans, Retrospective Studies, Nutrition and Dietetics, business.industry, Gold standard, Reflux, nutritional and metabolic diseases, Type 2 Diabetes Mellitus, Reference Standards, medicine.disease, Roux-en-Y anastomosis, Comorbidity, Obesity, Morbid, Surgery, Treatment Outcome, Diabetes Mellitus, Type 2, GERD, Female, Laparoscopy, 030211 gastroenterology & hepatology, medicine.symptom, business, Body mass index
الوصف: Laparoscopic Roux-en-Y gastric bypass (RYGB) is the oldest and most widely performed bariatric surgery worldwide. There is, however, a scarcity of mid- to long-term data of RYGB, especially from the Indian subcontinent. The study was a single-center, retrospective analysis from patients who underwent RYGB between January 2009 and November 2014 from a tertiary care center in India. Percent of total weight loss (%TWL) was taken as the primary outcome of the study. Secondary outcomes included type 2 diabetes mellitus (T2DM) remission, comorbidity resolution, revisional surgeries, and complications related to RYGB at 1 year, at 3 years, and during the long term, following surgery. Postoperative visits took place at 1 and 3 years, while the long-term outcome was at median 8.3 years (range 5.4–11.2 years), with a follow-up of 92.4% (488/528), 80.5% (424/527) and 69.5% (363/522), respectively. Out of 528 patients studied, 56% were females. The mean body mass index (BMI) was 40.6 ± 6.9 kg/m2. The %TWL in the long-term follow-up was 21.8 ± 11.3%. T2DM remission rates at 1 year, at 3 years, and during the long term were 84.5%, 70.0%, and 60.0%, respectively. Preoperative HBA1c (p = 0.002) and insulin usage (p = 0.016) had a significant predictive effect on T2DM remission. Gastroesophageal reflux disease (GERD) improved significantly (p 30 days) complications were observed in 2.3% and 4.3% of the patients, respectively. Weight loss during mid to long-term follow-up was maintained in the majority of the patients after RYGB. However, a small proportion had significant weight regain in the long term. T2DM, GERD, and other comorbidities were well improved after RYGB.
تدمد: 1708-0428
0960-8923
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb29fea2db4001a7a118cefd0b5ee1b1
https://doi.org/10.1007/s11695-020-04849-x
حقوق: CLOSED
رقم الأكسشن: edsair.doi.dedup.....eb29fea2db4001a7a118cefd0b5ee1b1
قاعدة البيانات: OpenAIRE